Randomized trial of [131I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation.
Bian H, Zheng JS, Nan G, Li R, Chen C, Hu CX, Zhang Y, Sun B, Wang XL, Cui SC, Wu J, Xu J, Wei D, Zhang X, Liu H, Yang W, Ding Y, Li J, Chen ZN.
Bian H, et al. Among authors: wu j.
J Natl Cancer Inst. 2014 Sep 10;106(9):dju239. doi: 10.1093/jnci/dju239. Print 2014 Sep.
J Natl Cancer Inst. 2014.
PMID: 25210200
Clinical Trial.